Table 1.
Preoperation and intraoperative information
| Variables | All (n = 1146) | Non-gastroparesis (n = 1051) | Gastroparesis (n = 95) | p-value |
|---|---|---|---|---|
| Sex | ||||
| Female | 530 (46.248) | 485 (46.147) | 45 (47.368) | 0.819 |
| Male | 616 (53.752) | 566 (53.853) | 50 (52.632) | |
| Age | ||||
| < 65 | 825 (71.990) | 785 (74.691) | 40 (42.105) | < 0.001 |
| ≥ 65 | 321 (28.010) | 266 (25.309) | 55 (57.895) | |
| BMI | ||||
| < 25 kg/m2 | 774 (67.539) | 722 (68.696) | 52 (54.737) | 0.005 |
| ≥ 25 kg/m2 | 372 (32.461) | 329 (31.304) | 43 (45.263) | |
| ASA | ||||
| < 3 | 761 (66.405) | 705 (67.079) | 56 (58.947) | 0.108 |
| ≥ 3 | 385 (33.595) | 346 (32.921) | 39 (41.053) | |
| Drinking history | ||||
| No | 773 (67.452) | 710 (67.555) | 63 (66.316) | 0.805 |
| Yes | 373 (32.548) | 341 (32.445) | 32 (33.684) | |
| Smoking history | ||||
| No | 795 (69.372) | 739 (70.314) | 56 (58.947) | 0.021 |
| Yes | 351 (30.628) | 312 (29.686) | 39 (41.053) | |
| ALB | ||||
| ≥ 30g/L | 813 (70.942) | 772 (73.454) | 41 (43.158) | < 0.001 |
| < 30g/L | 333 (29.058) | 279 (26.546) | 54 (56.842) | |
| NRS2002 score | ||||
| < 3 | 808 (70.506) | 744 (70.790) | 64 (67.368) | 0.484 |
| ≥ 3 | 338 (29.494) | 307 (29.210) | 31 (32.632) | |
| Surgical history | ||||
| No | 739 (64.485) | 692 (65.842) | 47 (49.474) | 0.001 |
| Yes | 407 (35.515) | 359 (34.158) | 48 (50.526) | |
| Anemia | ||||
| No | 859 (74.956) | 812 (77.260) | 47 (49.474) | < 0.001 |
| Yes | 287 (25.044) | 239 (22.740) | 48 (50.526) | |
| Hyperlipidemia | ||||
| No | 908 (79.232) | 840 (79.924) | 68 (71.579) | 0.055 |
| Yes | 238 (20.768) | 211 (20.076) | 27 (28.421) | |
| Hypertension | ||||
| No | 657 (57.330) | 609 (57.945) | 48 (50.526) | 0.162 |
| Yes | 489 (42.670) | 442 (42.055) | 47 (49.474) | |
| Diabetes | ||||
| No | 918 (80.105) | 869 (82.683) | 49 (51.579) | < 0.001 |
| Yes | 228 (19.895) | 182 (17.317) | 46 (48.421) | |
| Hypothyroidism | ||||
| No | 815 (71.117) | 774 (73.644) | 41 (43.158) | < 0.001 |
| Yes | 331 (28.883) | 277 (26.356) | 54 (56.842) | |
| COPD | ||||
| No | 950 (82.897) | 879 (83.635) | 71 (74.737) | 0.027 |
| Yes | 196 (17.103) | 172 (16.365) | 24 (25.263) | |
| CHD | ||||
| No | 970 (84.642) | 887 (84.396) | 83 (87.368) | 0.442 |
| Yes | 176 (15.358) | 164 (15.604) | 12 (12.632) | |
| Adjuvant radiotherapy | ||||
| No | 882 (76.963) | 818 (77.831) | 64 (67.368) | 0.02 |
| Yes | 264 (23.037) | 233 (22.169) | 31 (32.632) | |
| Adjuvant chemotherapy | ||||
| No | 852 (74.346) | 788 (74.976) | 64 (67.368) | 0.104 |
| Yes | 294 (25.654) | 263 (25.024) | 31 (32.632) | |
| Surgical procedure | ||||
| Laparoscopic surgery | 880 (76.789) | 823 (78.306) | 57 (60.000) | < 0.001 |
| Open surgery | 266 (23.211) | 228 (21.694) | 38 (40.000) | |
| Emergency surgery | ||||
| No | 820 (71.553) | 760 (72.312) | 60 (63.158) | 0.058 |
| Yes | 326 (28.447) | 291 (27.688) | 35 (36.842) | |
| Surgery time | ||||
| < 270 min | 754 (65.794) | 709 (67.460) | 45 (47.368) | < 0.001 |
| ≥ 270 min | 392 (34.206) | 342 (32.540) | 50 (52.632) | |
| Intraoperative bleeding | ||||
| < 100 ml | 766 (66.841) | 728 (69.267) | 38 (40.000) | < 0.001 |
| ≥ 100 ml | 380 (33.159) | 323 (30.733) | 57 (60.000) | |
| Blood transfusion | ||||
| No | 912 (79.581) | 840 (79.924) | 72 (75.789) | 0.338 |
| Yes | 234 (20.419) | 211 (20.076) | 23 (24.211) | |
| SPO2 | ||||
| ≥ 90% | 930 (81.152) | 855 (81.351) | 75 (78.947) | 0.566 |
| < 90% | 216 (18.848) | 196 (18.649) | 20 (21.053) | |
| T-stage | ||||
| T1–T2 | 831 (72.513) | 785 (74.691) | 46 (48.421) | < 0.001 |
| T3–T4 | 315 (27.487) | 266 (25.309) | 49 (51.579) | |
| N-stage | ||||
| N0 | 843 (73.560) | 785 (74.691) | 58 (61.053) | 0.004 |
| N1–N2 | 303 (26.440) | 266 (25.309) | 37 (38.947) | |
| PNI | ||||
| No | 1018 (88.831) | 938 (89.248) | 80 (84.211) | 0.135 |
| Yes | 128 (11.169) | 113 (10.752) | 15 (15.789) | |
| Tumor number | ||||
| < 2 | 870 (75.916) | 825 (78.497) | 45(47.368) | < 0.001 |
| ≥ 2 | 276 (24.084) | 226 (21.503) | 50 (52.632) | |
| Tumor size | ||||
| < 5 cm | 795 (69.372) | 751 (71.456) | 44 (46.316) | < 0.001 |
| ≥ 5 cm | 351 (30.628) | 300 (28.544) | 51 (53.684) | |
| CEA level | ||||
| < 5 ng/ml | 843 (73.560) | 768 (73.073) | 75 (78.947) | 0.214 |
| ≥ 5 ng/ml | 303 (26.440) | 283 (26.927) | 20 (21.053) | |
| CA19-9 level | ||||
| < 37 U/mL | 857 (74.782) | 785 (74.691) | 72 (75.789) | 0.813 |
| ≥ 37 U/mL | 289 (25.218) | 266 (25.309) | 23 (24.211) | |
| PCT level | ||||
| < 0.05 ng/ml | 848 (73.997) | 774 (73.644) | 74 (77.895) | 0.366 |
| ≥ 0.05 ng/ml | 298 (26.003) | 277 (26.356) | 21 (22.105) | |
| CRP level | ||||
| < 10 mg/l | 792 (69.110) | 741 (70.504) | 51 (53.684) | < 0.001 |
| ≥ 10 mg/l | 354 (30.890) | 310 (29.496) | 44 (46.316) | |
| SAA level | ||||
| < 10 mg/l | 833 (72.688) | 776 (73.834) | 57 (60.000) | 0.004 |
| ≥ 10 mg/l | 313 (27.312) | 275 (26.166) | 38 (40.000) |
OR, odds ratio; CI, confidence interval; BMI, body mass index; ASA, The American Society of Anesthesiologists; ALB, albumin; CA125, carbohydrate antigen 125; CA19-9, carbohydrate antigen 19–9; PCT, procalcitonin; CRP, C-reactive protein; SAA, serum amyloid A; NRS2002, nutrition risk screening 2002; CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease; SPO2, percutaneous arterial oxygen saturation